CARM1 arginine methyltransferase as a therapeutic target for cancer.

Santos, Margarida; Hwang, Jee Won; Bedford, Mark T

Santos, Margarida; Hwang, Jee Won; Bedford, Mark T.

Afiliación

Santos M; Department of Epigenetics & Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: mialmeidasantos@mdanderson.org.
Hwang JW; Department of Epigenetics & Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Bedford MT; Department of Epigenetics & Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: mtbedford@mdanderson.org.

J Biol Chem ; 299(9): 105124, 2023 09.

Article en En | MEDLINE | ID: mdl-37536629

Asunto(s)

Neoplasias; Proteína-Arginina N-Metiltransferasas; Animales; Humanos; Ratones; Sistemas de Liberación de Medicamentos; Neoplasias/tratamiento farmacológico; Neoplasias/genética; Factores de Transcripción/metabolismo; Proteína-Arginina N-Metiltransferasas/antagonistas & inhibidores; Proteína-Arginina N-Metiltransferasas/genética; Proteína-Arginina N-Metiltransferasas/metabolismo

Palabras clave

CARM1; Tudor domain; cancer; cancer therapeutics; epigenetics; small molecule inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Proteína-Arginina N-Metiltransferasas / Neoplasias Tipo de estudio: Prognostic_studies Idioma: En Revista: J Biol Chem Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google